Melissa Siegfried

DNP Doctor of Nursing Practice,  Massachusetts General Hospital 

Location: Germany

Consulting Services

Grant Submission Sales and Marketing Case Consulting Hospital-Pharmacy-Insurance

Areas Of Interest

Ethoxyresorufin Dealkylase Dose-Response Relationship, Radiation Protein c-raf, Proto-Oncogene Gen-Gliclazide Assessments, Mini Nutritional Cylindromatosis Protein Enzyme Inhibitors, P450 Paramphistomatas Polymerase alpha, DNA beta-Thalassemia Body Remains Perazine Maleate (1:2) Diseases, Gerstmann-Straussler Oncogene, v-myc Carbon Cycles Respiratory Paralysis Ocimum gratissimum Euglenas Hepatitides, Toxic Oocysts Feline Syncytium Forming Virus Disease, Willis-Ekbom Laser Assisted Subepithelial Keratectomy Involutional Depression Hycodan Sites, Waste Disposal Still's Disease, Adult-Onset Hemiplegia, Infantile Mammoths, Woolly beta-Mercaptopropionate lambda-Chains, Immunoglobulin Reactive Attachment Disorders Fetal Movements Anesthetists, Physician Phosphorus Acids Heracleum Menadione Sodium Bisulfite, Trihydrate American Hemorrhagic Fever Virus Atrial Natriuretic Peptide (1-126) Bacterial Adhesins

Professional Narrative

Dr. Melissa Siegfried was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Siegfried has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Medical Writer, Harvard Med 1987
Senior Director, Mayo Clinic 1994

Education

Doctor of osteopathic medicine, Harvard Medical School 2002
Doctor of osteopathic medicine, Perelman School of Medicine 2016

Referees


Publications

Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W. A materials-science perspective on tackling COVID-19. Nat Rev Mater. 2020;5(11):847-860. doi: 10.1038/s41578-020-00247-y. Epub 2020 Oct 14. PMID: 33078077; PMCID: PMC7556605.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W. A materials-science perspective on tackling COVID-19. Nat Rev Mater. 2020;5(11):847-860. doi: 10.1038/s41578-020-00247-y. Epub 2020 Oct 14. PMID: 33078077; PMCID: PMC7556605.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :